Gas challenge-blood oxygen level-dependent (GC-BOLD) MRI in the rat Novikoff hepatoma model

Magnetic Resonance Imaging

Volumn 30, Issue 1, 2012, Pages 133-138

  Guo, Yang ^a   Jin, Ning ^a,b   Klein, Rachel ^a   Nicolai, Jodi ^a   Yang, Guang Yu ^a   Omary, Reed A ^a,b   Larson, Andrew C ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

Author keywords

Gas challenge blood oxygen level dependent (GC BOLD); MRI; Rat Novikoff hepatoma; Tumor angiogenesis; Tumor microvessel density

Indexed keywords

BIOLOGICAL MARKER; CARBOGEN;

AMBIENT AIR; ANGIOGENESIS; ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING; CONTROLLED STUDY; CORRELATION ANALYSIS; GAS CHALLENGE BLOOD OXYGEN LEVEL DEPENDENT MAGNETIC RESONANCE IMAGING; HISTOPATHOLOGY; IMAGE RECONSTRUCTION; MALE; MEASUREMENT; NON INVASIVE MEASUREMENT; NONHUMAN; NOVIKOFF HEPATOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR MICROVESSEL DENSITY; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

ANIMALIA; RATTUS; RODENTIA;

EID: 82955247835     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2011.09.007     Document Type: Article

References (21)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
2. Ribatti D., Vacca A., Nico B., Sansonno D., Dammacco F. Angiogenesis and anti-angiogenesis in hepatocellular carcinoma. Cancer Treat Rev 2006, 32(6):437-444.
3. Kerbel R.S. Tumor angiogenesis. N Engl J Med 2008, 358(19):2039-2049.
4. Liu L., Cao Y., Chen C., Zhang X., McNabola A., Wilkie D., et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 2006, 66(24):11851-11858.
5. Maleddu A., Pantaleo M.A., Castellucci P., Astorino M., Nanni C., Nannini M., et al. 11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. Tumori 2009, 95(3):382-384.
6. Jiang H.J., Zhang Z.R., Shen B.Z., Wan Y., Guo H., Li J.P. Quantification of angiogenesis by CT perfusion imaging in liver tumor of rabbit. Hepatobiliary Pancreat Dis Int 2009, 8(2):168-173.
7. Oostendorp M., Post M.J., Backes W.H. Vessel growth and function: depiction with contrast-enhanced MR imaging. Radiology 2009, 251(2):317-335.
8. Bettmann M.A., Heeren T., Greenfield A., Goudey C. Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry. Radiology 1997, 203(3):611-620.
9. Baudelet C., Gallez B. Current issues in the utility of blood oxygen level dependent MRI for the assessment of modulations in tumor oxygenation. Curr Med Imaging Rev 2005, 1:229-243.
10. Thomas C.D., Chenu E., Walczak C., Plessis M.J., Perin F., Volk A. Relationship between tumour growth rate and carbogen-based functional MRI for a chemically induced HCC in mice. MAGMA 2004, 17(3-6):271-280.
11. Barash H., Gross E., Matot I., Edrei Y., Tsarfaty G., Spira G., et al. Functional MR imaging during hypercapnia and hyperoxia: noninvasive tool for monitoring changes in liver perfusion and hemodynamics in a rat model. Radiology 2007, 243(3):727-735.
12. Novikoff A.B. A transplantable rat liver tumor induced by 4-dimethy-laminoazobenzene. Cancer Res 1957, 17:1010-1027.
13. Guo Y., Zhang Y., Klein R., Nijm G.M., Sahakian A.V., Omary R.A., et al. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 2010, 70(4):1555-1563.
14. Jin N., Deng J., Chadashvili T., Zhang Y., Guo Y., Zhang Z., et al. Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis. Radiology 2010, 254(1):129-137.
15. Fox S.B., Harris A.L. Histological quantitation of tumour angiogenesis. APMIS 2004, 112(7-8):413-430.
16. Tanigawa N., Lu C., Mitsui T., Miura S. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology 1997, 26(5):1216-1223.
17. Guo Y., Klein R., Omary R.A., Yang G.Y., Larson A.C. Highly malignant intra-hepatic metastatic hepatocellular carcinoma in rats. Am J Transl Res 2010, 3(1):114-120.
18. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
19. Robinson S.P., Rijken P.F., Howe F.A., McSheehy P.M., van der Sanden B.P., Heerschap A., et al. Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry. J Magn Reson Imaging 2003, 17(4):445-454.
20. Thomas C.D., Chenu E., Walczak C., Plessis M.J., Perin F., Volk A. Morphological and carbogen-based functional MRI of a chemically induced liver tumor model in mice. Magn Reson Med 2003, 50(3):522-530.
21. Robinson S.P., Rodrigues L.M., Ojugo A.S., McSheehy P.M., Howe F.A., Griffiths J.R. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. Br J Cancer 1997, 75(7):1000-1006.